BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ghafouri-Fard S, Honarmand Tamizkar K, Hussen BM, Taheri M. MicroRNA signature in liver cancer. Pathol Res Pract 2021;219:153369. [PMID: 33626406 DOI: 10.1016/j.prp.2021.153369] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Gökalp F. The curative effect of some natural active compounds for liver cancer. Med Oncol 2022;40:57. [PMID: 36550238 DOI: 10.1007/s12032-022-01933-3] [Reference Citation Analysis]
2 Gao S, Jiang X, Wang L, Jiang S, Luo H, Chen Y, Peng C. The pathogenesis of liver cancer and the therapeutic potential of bioactive substances. Front Pharmacol 2022;13:1029601. [DOI: 10.3389/fphar.2022.1029601] [Reference Citation Analysis]
3 Malakootian M, Naeli P, Mowla SJ, Seidah NG. Post-Transcriptional Effects of miRNAs on PCSK7 Expression and Function: miR-125a-5p, miR-143-3p, and miR-409-3p as Negative Regulators. Metabolites 2022;12:588. [DOI: 10.3390/metabo12070588] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Yang L, Zou T, Chen Y, Zhao Y, Wu X, Li M, Du F, Chen Y, Xiao Z, Shen J. Hepatitis B virus X protein mediated epigenetic alterations in the pathogenesis of hepatocellular carcinoma. Hepatol Int 2022. [PMID: 35648301 DOI: 10.1007/s12072-022-10351-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Liu H, Wu N. Anti-Liver Cancer Activity of a New Compound Extracted from Populus pruinosa and Phylogenetic Analysis. sci adv mater 2022;14:971-978. [DOI: 10.1166/sam.2022.4277] [Reference Citation Analysis]
6 Sun M, Liu X, Wei W, Ge N, Luo S, Shen S, Ge R. BAP31 Promotes Proliferation, Invasion, and Metastasis of Liver Cancer Cells via Activating PI3K/AKT Pathway. J Healthc Eng 2022;2022:7686728. [PMID: 35449837 DOI: 10.1155/2022/7686728] [Reference Citation Analysis]
7 Hussen BM, Salihi A, Abdullah ST, Rasul MF, Hidayat HJ, Hajiesmaeili M, Ghafouri-Fard S. Signaling pathways modulated by miRNAs in breast cancer angiogenesis and new therapeutics. Pathol Res Pract 2022;230:153764. [PMID: 35032831 DOI: 10.1016/j.prp.2022.153764] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Zheng T, Zhang X, Wang Y, Wang A. SPOCD1 regulated by miR-133a-3p promotes hepatocellular carcinoma invasion and metastasis. J Int Med Res 2022;50:030006052110537. [DOI: 10.1177/03000605211053717] [Reference Citation Analysis]
9 Tait BD. The importance of establishing genetic phase in clinical medicine. Int J Immunogenet 2021. [PMID: 34958529 DOI: 10.1111/iji.12567] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
10 Hussen BM, Hidayat HJ, Salihi A, Sabir DK, Taheri M, Ghafouri-Fard S. MicroRNA: A signature for cancer progression. Biomed Pharmacother 2021;138:111528. [PMID: 33770669 DOI: 10.1016/j.biopha.2021.111528] [Cited by in Crossref: 29] [Cited by in F6Publishing: 35] [Article Influence: 14.5] [Reference Citation Analysis]